Relationship Between FGF19 Overexpression and Disease Prognosis

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

OTHER

This is an observational study and does not involve an intervention

Trial Locations (1)

Beijing Tsinghua Changgung Hospital, Beijing

All Listed Sponsors

lead

Beijing Tsinghua Chang Gung Hospital

OTHER

NCT06938451 - Relationship Between FGF19 Overexpression and Disease Prognosis | Biotech Hunter | Biotech Hunter